Unlike previous reports that primarily associated furin activity with the processing of general oncogenic substrates or KRAS/BRAF-driven tumorigenesis [21,22,32], our study uniquely identifies a positive feedback loop between furin and TGF-β that sustains ERK activation and drives both tumor progression and 5-Fu resistance. The gene discussed is KRAS; the disease is neoplasm.